Loading…
Loading grant details…
| Funder | NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES |
|---|---|
| Recipient Organization | Trustees of Indiana University |
| Country | United States |
| Start Date | Jul 10, 2024 |
| End Date | Apr 30, 2029 |
| Duration | 1,755 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | NIH (US) |
| Grant ID | 10765058 |
Project Summary DNA double-strand break (DSB) is one of the most toxic DNA lesions in cells. DSB causes immediate chromosome breakage and must be repaired before chromosome segregation. Unfaithful repair of DSB may lead to genome rearrangements and ultimately tumorigenesis. Research in my laboratory strives to define the mechanism and regulation of DSB repair where
homologous recombination (HR) serves as a major repair means. Eukaryotic single-stranded DNA binding protein, RPA, as a universal DNA replication and repair factor, is involved in multiple stages of the HR pathway including the DSB end resection by the Sgs1-Dna2 helicase/nuclease ensemble. Our recent work discovered RPA as a processive unit for Dna2-
catalyzed ssDNA digestion, which provided a novel perspective on the regulation of ssDNA accessibility by RPA and inspired us to explore how RPA may serve as an integral component of the Sgs1-Dna2 machinery and coordinate their actions. Unexpectedly, our work on the Dna2- RPA ensemble revealed a novel role of Dna2 in the processing of an undefined intermediate in
DSB repair likely derived from DNA repair synthesis and led us to discover an RPA mutant that constitutively dimerizes, which may serve as a powerful tool to understand the function of RPA dimerization. Both directions will also be explored in this proposal. Given the conservation of the HR pathway between yeast and humans, our work will shed light on the mechanism of DSB
repair not only in yeast but also in human cells.
Trustees of Indiana University
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant